AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

2-Day Seminar on Nasal Drug Delivery (London, United Kingdom - April 11-12, 2019) - ResearchAndMarkets.com

February 22, 2019

DUBLIN--(BUSINESS WIRE)--Feb 22, 2019--The “Nasal Drug Delivery” conference has been added to ResearchAndMarkets.com’s offering.

This conference gives a comprehensive review within the field of nasal drug delivery while reviewing interesting new data and innovative technologies

What makes nasal delivery systems more challenging than solid dosage forms? How safe is nasal drug delivery? Are there such things as safe excipients? How does all this fit within the regulatory environment in Europe and the USA? How difficult is it to bring all these products to market?

This seminar seeks to explore these and other questions within the field of nasal drug delivery while reviewing interesting new data, innovative technologies and the very latest scientific developments. Leading authorities in nasal drug delivery will cover relevant aspects of nasal physiology, anatomy, absorption of a variety of drugs in various phases of drug development, and new drugs entering the market. In addition, nasal delivery to the sinuses will be discussed and the programme will include interesting case histories.

The seminar will offer an excellent networking opportunity to build business relationships and discuss all these issues with an unrivalled panel of experts in this field of drug delivery.

Three reasons to attend:

1. Gain an update on the very latest scientific developments and technology advances in this field

2. Hear from an unrivalled panel of expert speakers

3. An excellent networking opportunity to build business relationships

Who Should Attend?

Those already involved in nasal drug delivery will benefit from updating their knowledge and sharing experiences with some of the leading practitioners in this field. If you are involved in nasal drug delivery or are just considering the potential, this seminar is an excellent route to understanding all aspects from the basic physiology through to launching a successful product.

Agenda

Nasal drugs to treat nasal disorders: a comprehensive review

Nasal drug delivery challenges

Nasal formulation of drugs

Developing next generation powder nasal delivery using POD technology

Rethinking nasal packaging environment

Key insights for a successful device development to achieve nasal bioequivalence requirements

The unique challenges of nasal drug delivery to treat chronic rhinosinusitis (CRS); considerations before and after sinus surgery

Review of nasal drug delivery devices

Requirements concerning bioequivalence of nasal drug products from an authority’s point of view

Regulatory science associated with BE/TE for nasal products

US/FDA regulatory guidance on combination products

Qualification of new nasal drug delivery systems for existing drugs

Investigations regarding the developability of nasal metered dose inhalers

What are chemisimilars and what’s the problem?

Discussion session

Concluding remarks

Close of conference and refreshments

For more information about this conference visit https://www.researchandmarkets.com/research/k79ns8/2day_seminar_on?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190222005337/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Transdermal and Transmucosal Drug Delivery

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 02/22/2019 10:43 AM/DISC: 02/22/2019 10:43 AM

http://www.businesswire.com/news/home/20190222005337/en